Table 1. Clinical features.
| Variable | N (%) | |
|---|---|---|
| Time from symptom onset until presentation (days) | 52.6±56.4 | |
| Underlying pathology | ||
| Rheumatic | 30 (37) | |
| Prosthetic valve | 21 (26) | |
| Normal heart | 19 (23.5) | |
| Congenital heart disease | 7 (8.6) | |
| Degenerative valve disease | 4 (5) | |
| Mitral valve | 46 (56.8) | |
| Aortic valve | 19 (23.5) | |
| Both valves | 13 (16) | |
| VSD, PDA, Ao root | 3 (3.7) | |
| Healthcare-associated endocarditis* | 25 (30.9) | |
| Organisms | ||
| Staph | 20 (24.7) | |
| Fungal | 8 (10) | |
| Strept | 14 (17.3) | |
| Brucella | 8 (10) | |
| Culture/serology negative | 15 (18.5) | |
| Other | 24 (29.6) | |
| Clinically symptomatic neurological complications | 34 (42) | |
| Any Major complication** | 63 (77.8) | |
| Sepsis requiring ventilation or vasopressor | 23 (28.4) | |
| Systemic embolization other than CNS | 49 (60.5) | |
| Heart failure | 40 (49.4) | |
| Death | 15(18.5) | |
*defined as, 1. Nosocomial infection: infection contracted ≥ 48 hours after hospital admission. 2. Non nosocomial infection: infection appearing ≤ 48 hours of hospital admission within: a) 1 month of receiving IV cannulation, chemotherapy or dialysis; b) 3 months of admission into an acute care facility, c) any time of admission to a nursing home.
**sepsis, major artery embolization, heart failure, death.